scholarly journals Plasma prevalence of anti-N-methyl-d-aspartate receptor IgG antibodies in early stages of psychosis

2021 ◽  
Vol 26 (3) ◽  
pp. 1085-1094
Author(s):  
Camila Marcelino Loureiro ◽  
Fabiana Corsi-Zuelli ◽  
Helene Aparecida Fachim ◽  
Rosana Shuhama ◽  
Natália Mota de Souza Chagas ◽  
...  

Abstract We investigated the feasibility of including plasma anti-NMDAR antibody screening in the assessment of first-episode psychosis patients in an early intervention programme in the Southern hemisphere. Anti-NMDAR IgG antibodies were assessed by ELISA in 166 patients (64.0% men), 166 matched population-based controls and 76 patients’ siblings (30.3% men). Fisher’s exact test and ANOVA were performed. Positive anti-NMDAR antibody patients were more often observed in bipolar disorder (10.0%) than schizophrenia (2.4%) or psychotic depression (3.1%), although no significant differences were observed. Our results are not conclusive regarding the inclusion of plasma anti-NMDAR IgG antibodies in differential diagnostic protocols for psychosis.

2018 ◽  
Vol 49 (12) ◽  
pp. 2091-2099 ◽  
Author(s):  
Kelly K. Anderson ◽  
Ross Norman ◽  
Arlene G. MacDougall ◽  
Jordan Edwards ◽  
Lena Palaniyappan ◽  
...  

AbstractBackgroundDiscrepancies between population-based estimates of the incidence of psychotic disorder and the treated incidence reported by early psychosis intervention (EPI) programs suggest additional cases may be receiving services elsewhere in the health system. Our objective was to estimate the incidence of non-affective psychotic disorder in the catchment area of an EPI program, and compare this to EPI-treated incidence estimates.MethodsWe constructed a retrospective cohort (1997–2015) of incident cases of non-affective psychosis aged 16–50 years in an EPI program catchment using population-based linked health administrative data. Cases were identified by either one hospitalization or two outpatient physician billings within a 12-month period with a diagnosis of non-affective psychosis. We estimated the cumulative incidence and EPI-treated incidence of non-affective psychosis using denominator data from the census. We also estimated the incidence of first-episode psychosis (people who would meet the case definition for an EPI program) using a novel approach.ResultsOur case definition identified 3245 cases of incident non-affective psychosis over the 17-year period. We estimate that the incidence of first-episode non-affective psychosis in the program catchment area is 33.3 per 100 000 per year (95% CI 31.4–35.1), which is more than twice as high as the EPI-treated incidence of 18.8 per 100 000 per year (95% CI 17.4–20.3).ConclusionsCase ascertainment strategies limited to specialized psychiatric services may substantially underestimate the incidence of non-affective psychotic disorders, relative to population-based estimates. Accurate information on the epidemiology of first-episode psychosis will enable us to more effectively resource EPI services and evaluate their coverage.


2007 ◽  
Vol 90 (1-3) ◽  
pp. 338-343 ◽  
Author(s):  
A AYRES ◽  
G BUSATTO ◽  
P MENEZES ◽  
M SCHAUFELBERGER ◽  
L COUTINHO ◽  
...  

2017 ◽  
Vol 82 (10) ◽  
pp. 766-772 ◽  
Author(s):  
Julie Jézéquel ◽  
Véronique Rogemond ◽  
Thomas Pollak ◽  
Marilyn Lepleux ◽  
Leslie Jacobson ◽  
...  

2019 ◽  
Vol 13 (6) ◽  
pp. 1525-1529
Author(s):  
Ricardo Coentre ◽  
Tiago Mendes ◽  
Ana Rebelo ◽  
Alexandra Fonseca ◽  
Pedro Levy

Sign in / Sign up

Export Citation Format

Share Document